These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27547226)

  • 1. Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials.
    Zhu JJ; Liu S; Su XL; Wang ZS; Guo Y; Li YJ; Yang Y; Hou LW; Wang QG; Wei RH; Yang JQ; Wei W
    Evid Based Complement Alternat Med; 2016; 2016():4071260. PubMed ID: 27547226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Xiao Y; Liu Y; Huang S; Sun X; Tang Y; Cheng J; Wang T; Li F; Kuang Y; Luo R; Zhao X
    PLoS One; 2015; 10(4):e0122397. PubMed ID: 25853241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials.
    Dai YK; Li DY; Zhang YZ; Huang MX; Zhou YL; Ye JT; Wang Q; Hu L
    PLoS One; 2018; 13(2):e0192319. PubMed ID: 29408906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials.
    Liang SB; Cao HJ; Kong LY; Wei JL; Robinson N; Yang SH; Zhu SJ; Li YQ; Fei YT; Han M; Liu JP
    Front Pharmacol; 2022; 13():904657. PubMed ID: 36091782
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Zheng Y; Yu T; Tang Y; Xiong W; Shen X; Jiang L; Lin L
    PLoS One; 2017; 12(3):e0172846. PubMed ID: 28291778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Tang XD; Lu B; Li ZH; Wei W; Meng LN; Li BS; Tang ZP; Gao R; Wang FY; Lu F; Bian LQ; Zhao YP; Wang P; Zhang YQ
    Chin J Integr Med; 2018 Sep; 24(9):645-652. PubMed ID: 27487786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
    Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acupuncture for Adults with Diarrhea-Predominant Irritable Bowel Syndrome or Functional Diarrhea: A Systematic Review and Meta-Analysis.
    Guo J; Xing X; Wu J; Zhang H; Yun Y; Qin Z; He Q
    Neural Plast; 2020; 2020():8892184. PubMed ID: 33299403
    [No Abstract]   [Full Text] [Related]  

  • 11. Acupuncture for treatment of irritable bowel syndrome.
    Lim B; Manheimer E; Lao L; Ziea E; Wisniewski J; Liu J; Berman B
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005111. PubMed ID: 17054239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
    Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture plus Chinese Herbal Medicine for Irritable Bowel Syndrome with Diarrhea: A Systematic Review and Meta-Analysis.
    Yan J; Miao ZW; Lu J; Ge F; Yu LH; Shang WB; Liu LN; Sun ZG
    Evid Based Complement Alternat Med; 2019; 2019():7680963. PubMed ID: 31110553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
    Qi Q; Zhang Y; Chen F; Zuo X; Li Y
    BMC Gastroenterol; 2018 Jan; 18(1):5. PubMed ID: 29310568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tegaserod for the treatment of irritable bowel syndrome.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
    Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
    Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis.
    Zhang FM; Li S; Ding L; Xiang SH; Zhu HT; Yu JH; Xu GQ
    Medicine (Baltimore); 2019 Jul; 98(28):e16297. PubMed ID: 31305414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological treatments for the management of irritable bowel syndrome.
    Zijdenbos IL; de Wit NJ; van der Heijden GJ; Rubin G; Quartero AO
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006442. PubMed ID: 19160286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.